01 / Monoclonal antibodies
Investigating a CHO process transfer across manufacturing sites
A transfer investigation connecting matched batch cohorts, temperature-transition timing and a product-specific quality panel.
ENTERPRISE USE CASES / SEVEN MODALITIES
Different process questions.
A clearer path to a decision.
Explore how connected evidence, scientific analysis and expert review can support enterprise investigations across programs, sites and partners.
These are proposed enterprise workflows, not measured customer outcomes. Integration, model suitability and review behavior are verified for the intended deployment.
02 / Microbial fermentation
Separating fermentation productivity loss from recovery loss
An enterprise investigation reconciling assay basis, production-phase accounting and recovery performance across a fermentation network.
03 / Chemical & pharmaceutical APIs
Investigating an API impurity shift after CDMO transfer
A route-step investigation separating analytical-method effects, reaction execution and impurity behavior through isolation.
04 / Recombinant proteins
Preserving protein activity through enterprise purification
An expression-to-purification investigation that separates recovered protein mass from retained biological activity.
05 / Cell therapies
Separating starting-material variability from cell-process performance
An autologous cell-therapy development use case connecting material attributes, stage performance, viable yield and product-specific potency.
06 / Gene therapies / AAV
Reconciling vector yield, recovery and potency across AAV campaigns
A vector-process use case connecting production, fraction recovery, capsid attributes, genome evidence and functional assessment.
07 / RNA & oligonucleotides
Balancing oligonucleotide purity and recovery across synthesis campaigns
A synthetic ASO-focused use case connecting sequence/process context, impurity characterization and purification pooling.
START WITH YOUR QUESTION
Make the next investigation
specific to your process.
Bring the decision, its owner and the evidence available. We will map the workflow and the review criteria together.
Discuss your use case ↗